Cansortium completed the acquisition of RIV Capital for $160m.

Cansortium, a vertically integrated, multi-state cannabis company, completed the acquisition of RIV Capital, a cannabis acquisition and investment firm, for $160m. "I view joining forces with RIV Capital as a natural progression in the expansion of Cansortium. With the addition of the New York cannabis market, Cansortium is expected to hold the distinction of operating in 4 of the 5 highest population states in the US following the closing of the Transaction. Additionally, the resources and market expertise that are expected to be leveraged from RIV Capital and Hawthorne will help position Cansortium to capitalize on the inevitable regulatory changes expected in the U.S. cannabis industry," William Smith, Cansortium Executive Chair.